|
⚲
|
| Keyboard |
| Harris John David
✚
|
|
|---|---|
| CIK # | 0001655866 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001655866] | |
| 4 | [0001655866] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Harris John David | |
| Plus Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Plus Therapeutics Inc CTYX
Warrants (Right to Buy) · derivative
|
2017-11-28 | Option exercise | 1,800 | ||
|
Plus Therapeutics Inc CTYX
Series B Preferred Stock · derivative
|
2017-11-28 | Option exercise | 1 | ||
|
Plus Therapeutics Inc CTYX
Subscription Rights (Right to Buy) · derivative
|
2017-11-28 | Option exercise | 1 | ||
|
Plus Therapeutics Inc CTYX
Incentive Stock Option (right to buy) · derivative
|
2017-03-08 | Grant | 42,000 | $0.00 | |
|
Plus Therapeutics Inc CYTX
Common Stock
|
2016-08-10 | Buy | 2,500 | $2.03 | 5,075 |
|
Plus Therapeutics Inc CYTX
Subscription Rights (Right to Buy) · derivative
|
2016-06-15 | Option exercise | 2,500 | $0.00 | |
|
Plus Therapeutics Inc CYTX
Common Stock
|
2016-06-15 | Option exercise | 2,500 | ||
|
Plus Therapeutics Inc CYTX
Warrants (Right to Buy) · derivative
|
2016-06-15 | Option exercise | 1,250 | ||
|
Plus Therapeutics Inc CYTX
Common Stock
|
2016-05-13 | Buy | 2,000 | $2.71 | 5,420 |
|
Plus Therapeutics Inc CYTX
Employee Stock Option · derivative
|
2016-01-04 | Grant | 349,830 | $0.00 | |
|
Plus Therapeutics Inc CYTX
Stock Option (Right to Buy) · derivative
|
2015-11-11 | Grant | 335,000 | $0.00 |